Literature DB >> 140191

Accumulation of platelets at sites of antigen-antibody-mediated injury: a possible role for IgE antibody and mast cells.

T C Kravis, P M Henson.   

Abstract

Circulating 51Cr-labeled platelets accumulate at skin sites in which a reversed passive Arthus reaction has been induced. The accumulation is biphasic in time and is accompanied by an increased vascular permeability. Increased permeability itself, however, will not produce localization of platelets. A similar platelet accumulation was observed upon injection of compound 48/80 or anti-IgE antibody into the skin and this was not altered in rabbits depleted of complement or neutrophils. Activation of skin mast cells and release of a platelet-activating factor (PAF) is suggested as a mechanism for the effect produced by anti-IgE and compound 48/80. The first phase of platelet accumulation in the Arthus reaction was also unaffected in rabbits depleted of neutrophils or complement, which may suggest a role for IgE antibody and mast cells. The second phase of accumulation was diminished in complement-depleted animals and abrogated in rabbits without neutrophils, suggesting a complement and neutrophil-mediated process but which still might be mediated through mast cell activation by neutrophil cationic protein.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 140191

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

Review 1.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

2.  An anti-inflammatory steroid inhibits tissue sensitization by IgE in vivo.

Authors:  P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

Review 3.  Immunological concepts and the eye: a review of the classical and ocular arthus reactions.

Authors:  L D Ormerod
Journal:  Doc Ophthalmol       Date:  1986       Impact factor: 2.379

4.  Platelet activating factor: regulation by mast cells and aspirin.

Authors:  J A Denburg; D B Williams; R L Kinlough-Rathbone; J P Cazenave; J Bienenstock
Journal:  Agents Actions       Date:  1984-02

Review 5.  Platelet-activating factor (PAF-acether): present status.

Authors:  J Benveniste
Journal:  Agents Actions       Date:  1981-12

6.  Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria.

Authors:  P G Holt; B J Holt; L Beijer; R Rylander
Journal:  Clin Exp Immunol       Date:  1983-01       Impact factor: 4.330

7.  Differential effects of pharmacologic agents on the reverse passive Arthus reaction in guinea pigs.

Authors:  Z E Mielens; J C Bhandari; T A Barbolt; V J Stecher
Journal:  Agents Actions       Date:  1984-10

8.  Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.

Authors:  F Pons; A G Rossi; K E Norman; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Platelet activating factor: an inhibitor of neutrophil activation?

Authors:  M C O'Donnell; J N Siegel; B A Fiedel
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

10.  Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.

Authors:  F Gonzalez-Crussi; W Hsueh
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.